Showing 1 - 20 results of 65 for search 'Myung-Ju Ahn', query time: 0.05s Refine Results
  1. 1
    Current status of immune checkpoint inhibitors in treatment of non-small cell lung cancer

    Current status of immune checkpoint inhibitors in treatment of non-small cell lung cancer by Sung Won Lim, Myung-Ju Ahn

    Published 2019-01-01
    Get full text
    Article
  2. 2
    The Effectiveness of Maintenance Pharmacotherapies for Non-Small Cell Lung Cancer

    The Effectiveness of Maintenance Pharmacotherapies for Non-Small Cell Lung Cancer by Myung-Ju Ahn, Jong-Mu Sun, Jin Sock Ahn, Keunchil Park

    Published 2012-01-01
    Get full text
    Article
  3. 3
    The Effectiveness of Maintenance Pharmacotherapies for Non-Small Cell Lung Cancer

    The Effectiveness of Maintenance Pharmacotherapies for Non-Small Cell Lung Cancer by Myung-Ju Ahn, Jong-Mu Sun, Jin Sock Ahn, Keunchil Park

    Published 2012-06-01
    Get full text
    Article
  4. 4
    Metastatic Squamous Cell Carcinoma from Lung Adenocarcinoma after Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy

    Metastatic Squamous Cell Carcinoma from Lung Adenocarcinoma after Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy by Hyung Kyu Park, Youjeong Seo, Yoon-La Choi, Myung-Ju Ahn, Joungho Han

    Published 2017-07-01
    Get full text
    Article
  5. 5
    The prognostic value of radiomic features from pre- and post-treatment 18F-FDG PET imaging in patients with nasopharyngeal carcinoma

    The prognostic value of radiomic features from pre- and post-treatment 18F-FDG PET imaging in patients with nasopharyngeal carcinoma by Soo Jeong Kim, Joon Young Choi, Yong Chan Ahn, Myung-Ju Ahn, Seung Hwan Moon

    Published 2023-05-01
    Get full text
    Article
  6. 6
    Prognostic Significance of Pseudotime from Texture Parameters of FDG PET/CT in Locally Advanced Non-Small-Cell Lung Cancer with Tri-Modality Therapy

    Prognostic Significance of Pseudotime from Texture Parameters of FDG PET/CT in Locally Advanced Non-Small-Cell Lung Cancer with Tri-Modality Therapy by Hyunjong Lee, Hojoong Kim, Yong Soo Choi, Hong Ryul Pyo, Myung-Ju Ahn, Joon Young Choi

    Published 2022-08-01
    Get full text
    Article
  7. 7
    Prognostic value of FOXP3+ regulatory T cells for patients with locally advanced oropharyngeal squamous cell carcinoma

    Prognostic value of FOXP3+ regulatory T cells for patients with locally advanced oropharyngeal squamous cell carcinoma by Joon Young Hur, Bo Mi Ku, Sehhoon Park, Hyun Ae Jung, Se-Hoon Lee, Myung-Ju Ahn

    Published 2022-01-01
    Get full text
    Article
  8. 8
    Prognostic value of FOXP3+ regulatory T cells for patients with locally advanced oropharyngeal squamous cell carcinoma.

    Prognostic value of FOXP3+ regulatory T cells for patients with locally advanced oropharyngeal squamous cell carcinoma. by Joon Young Hur, Bo Mi Ku, Sehhoon Park, Hyun Ae Jung, Se-Hoon Lee, Myung-Ju Ahn

    Published 2022-01-01
    Get full text
    Article
  9. 9
    Clues to occult cancer in patients with ischemic stroke.

    Clues to occult cancer in patients with ischemic stroke. by Suk Jae Kim, Jae Hyun Park, Mi-Ji Lee, Yun Gyoung Park, Myung-Ju Ahn, Oh Young Bang

    Published 2012-01-01
    Get full text
    Article
  10. 10
    Cancer-Related Stroke: An Emerging Subtype of Ischemic Stroke with Unique Pathomechanisms

    Cancer-Related Stroke: An Emerging Subtype of Ischemic Stroke with Unique Pathomechanisms by Oh Young Bang, Jong-Won Chung, Mi Ji Lee, Woo-Keun Seo, Gyeong-Moon Kim, Myung-Ju Ahn

    Published 2020-01-01
    Get full text
    Article
  11. 11
    Radiomics Analysis of <sup>18</sup>F-FDG PET/CT for Prognosis Prediction in Patients with Stage III Non-Small Cell Lung Cancer Undergoing Neoadjuvant Chemoradiation Therapy Followed by Surgery

    Radiomics Analysis of <sup>18</sup>F-FDG PET/CT for Prognosis Prediction in Patients with Stage III Non-Small Cell Lung Cancer Undergoing Neoadjuvant Chemoradiation Therapy Followe... by Jang Yoo, Jaeho Lee, Miju Cheon, Hojoong Kim, Yong Soo Choi, Hongryull Pyo, Myung-Ju Ahn, Joon Young Choi

    Published 2023-03-01
    Get full text
    Article
  12. 12
    Treatment and Outcomes of Metastatic Non-Small-Cell Lung Cancer Harboring Uncommon <i>EGFR</i> Mutations: Are They Different from Those with Common <i>EGFR</i> Mutations?

    Treatment and Outcomes of Metastatic Non-Small-Cell Lung Cancer Harboring Uncommon <i>EGFR</i> Mutations: Are They Different from Those with Common <i>EGFR</i> Mutations? by Hyun Ae Jung, Sehhoon Park, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahn, Keunchil Park

    Published 2020-10-01
    Get full text
    Article
  13. 13
    Clinical outcomes of immune checkpoint inhibitors for patients with recurrent or metastatic head and neck cancer: real-world data in Korea

    Clinical outcomes of immune checkpoint inhibitors for patients with recurrent or metastatic head and neck cancer: real-world data in Korea by Hyera Kim, Minsuk Kwon, Binnari Kim, Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Keunchil Park, Myung-Ju Ahn

    Published 2020-08-01
    Get full text
    Article
  14. 14
    Prognostic value of pretherapeutic FDG PET/CT in non-small cell lung cancer with pulmonary lymphangitic carcinomatosis

    Prognostic value of pretherapeutic FDG PET/CT in non-small cell lung cancer with pulmonary lymphangitic carcinomatosis by Yong-Jin Park, Yunjoo Im, O. Jung Kwon, Joungho Han, Myung-Ju Ahn, Jhingook Kim, Sang-Won Um, Joon Young Choi

    Published 2023-01-01
    Get full text
    Article
  15. 15
    Real-World Outcomes of Immunotherapy in Second- or Later-Line Non-Small Cell Lung Cancer with Actionable Genetic Alterations

    Real-World Outcomes of Immunotherapy in Second- or Later-Line Non-Small Cell Lung Cancer with Actionable Genetic Alterations by Soojin Jun, Sehhoon Park, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahn, Juhee Cho, Hyun Ae Jung

    Published 2023-11-01
    Get full text
    Article
  16. 16
    435 Pegasus HNSCC, a platform study of SAR444245 (THOR-707, a pegylated recombinant non-alpha IL-2) with anti-cancer agents in patients with recurrent/metastatic head and neck squamous cell carcinoma

    435 Pegasus HNSCC, a platform study of SAR444245 (THOR-707, a pegylated recombinant non-alpha IL-2) with anti-cancer agents in patients with recurrent/metastatic head and neck squa... by Myung Ju Ahn, Lisa Licitra, Caroline Even, Chia-Jui Yen, George Blumenschein, Robin Meng, Giovanni Abbadessa, Fatima-Zohra Menas, Miao Zang

    Published 2021-11-01
    Article
  17. 17
    PD‐1 inhibitors for non‐small cell lung cancer patients with special issues: Real‐world evidence

    PD‐1 inhibitors for non‐small cell lung cancer patients with special issues: Real‐world evidence by Seonggyu Byeon, Jang Ho Cho, Hyun Ae Jung, Jong‐Mu Sun, Se‐Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung‐Ju Ahn

    Published 2020-04-01
    Get full text
    Article
  18. 18
    Safety and tolerability of first‐line durvalumab with tremelimumab and chemotherapy in esophageal squamous cell carcinoma

    Safety and tolerability of first‐line durvalumab with tremelimumab and chemotherapy in esophageal squamous cell carcinoma by Dae Ho Lee, Hye Ryun Kim, Bhumsuk Keam, Ken Kato, Yasutoshi Kuboki, Haiyan Gao, Alejandro Yovine, Scott H. Robbins, Myung‐Ju Ahn

    Published 2023-08-01
    Get full text
    Article
  19. 19
    Prognostic Significance of Volumetric Parameters Based on FDG PET/CT in Patients with Lung Adenocarcinoma Undergoing Curative Surgery

    Prognostic Significance of Volumetric Parameters Based on FDG PET/CT in Patients with Lung Adenocarcinoma Undergoing Curative Surgery by Hyunjong Lee, Yoon-La Choi, Hong Kwan Kim, Yong Soo Choi, Hojoong Kim, Myung-Ju Ahn, Hong Ryul Pyo, Joon Young Choi

    Published 2023-09-01
    Get full text
    Article
  20. 20
    Clinical Value of Surveillance <sup>18</sup>F-fluorodeoxyglucose PET/CT for Detecting Unsuspected Recurrence or Second Primary Cancer in Non-Small Cell Lung Cancer after Curative Therapy

    Clinical Value of Surveillance <sup>18</sup>F-fluorodeoxyglucose PET/CT for Detecting Unsuspected Recurrence or Second Primary Cancer in Non-Small Cell Lung Cancer after Curative T... by Chae Hong Lim, Soo Bin Park, Hong Kwan Kim, Yong Soo Choi, Jhingook Kim, Yong Chan Ahn, Myung-ju Ahn, Joon Young Choi

    Published 2022-01-01
    Get full text
    Article

Search Tools: